COMMUNIQUÉS West-GlobeNewswire

-
MyoKardia Shares Data from Ongoing Clinical Programs and Details Three New Research Programs at 2018 R&D Day
30/10/2018 -
Resonant to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, November 13th at 1:30 p.m. Pacific Standard Time
30/10/2018 -
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
30/10/2018 -
Rapid Micro Biosystems Announces New Chief Financial Officer
30/10/2018 -
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia (PDD)
30/10/2018 -
Hospital Authority of Hong Kong Selects Mach7 and Client Outlook for Enterprise Imaging Contract
30/10/2018 -
Aleafia Labs Partners on Cannabinoid Pharmacogenetics Study
30/10/2018 -
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
30/10/2018 -
Antares Pharma to Report Third Quarter 2018 Financial and Operating Results
30/10/2018 -
EyePoint Pharmaceuticals Appoints John Landis, Ph.D., M.S., to Board of Directors
30/10/2018 -
Maple Leaf Enters into a Supply Agreement with Cannmart Inc.
30/10/2018 -
TRU NIAGEN® Recognized as Best Product & Most Popular Brand at Health, Wellness & Beauty Awards 2018 of Watsons Hong Kong
30/10/2018 -
Correction to third quarter 2018 financial statements
30/10/2018 -
Transactions in relation to share buyback program
30/10/2018 -
CorVel Announces Revenues and Earnings
30/10/2018 -
G1 Therapeutics to Provide Third Quarter 2018 Corporate and Financial Update on November 7, 2018
30/10/2018 -
Orion Corporation: Managers' transactions - Konsta Westerlund
30/10/2018 -
Verona Pharma to Announce Interim Results for Nine Months Ended September 30, 2018 and Provide Clinical Development Update
30/10/2018 -
Clementia Announces Pricing of Public Offering of Common Shares
30/10/2018
Pages